SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q1 2020 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS)
Q1 2020 Earnings Conference Call
May 07, 2020, 08:30 ET
Company Participants
Naomi Aoki - VP, Corporate Communications & IR
Nancy Simonian - President, CEO & Director
Joseph Ferra - CFO
David Roth - Chief Medical Officer
Conference Call Participants
Philip Nadeau - Cowen and Company
Zegbeh Jallah - Roth Capital Partners
Presentation
Operator
Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2020 Financial Results Conference Call. [Operator Instructions].
At this time, I would like to turn the call over to Naomi Aoki, Vice President of Corporate Communications and Investor